Growth hormone dosing variables in growth hormone-deficient adults

Growth Hormone and IGF Research

Volumn 16, Issue SUPPL., 2006, Pages 49-54

  Cook, David M ^a   Yuen, Kevin C J ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Adult; Dose adjustment; Growth hormone deficiency; Safety

Indexed keywords

ARGININE; ESTROGEN; GROWTH HORMONE RELEASING FACTOR; INSULIN; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARPAL TUNNEL SYNDROME; CONSENSUS; CONSULTATION; CONTROLLED STUDY; DRUG APPROVAL; DRUG DOSE REGIMEN; DUAL ENERGY X RAY ABSORPTIOMETRY; ESTROGEN THERAPY; EUROPE; FEMALE; FOOD AND DRUG ADMINISTRATION; GENDER; GROWTH HORMONE DEFICIENCY; HUMAN; HYPOPHYSIS TUMOR; HYPOPITUITARISM; LIPOLYSIS; MAJOR CLINICAL STUDY; MALE; MYALGIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT; SYMPTOM; TREATMENT DURATION; UNITED STATES;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; DWARFISM, PITUITARY; FOLLOW-UP STUDIES; GROWTH HORMONE; HUMANS; OFFICE VISITS; POPULATION; TITRIMETRY; TREATMENT OUTCOME;

EID: 33745221649     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2006.03.007     Document Type: Article

References (11)

1. Zadik Z., Chalew S.A., McCarter R.J., Meistas M., and Kowarski A.A. The influence of age on the 24 hour integrated concentration of growth hormone in normal individuals. J. Clin. Endocrinol. Metab. 60 (1985) 513-516
2. DeBoer H., Blok G.-J., and Van Der Veen E. Clinical aspects of growth hormone deficiency in adults. Endocr. Rev. 17 (1995) 63-86
3. Shah N., Aloi J., Evan S., and Veldhuis J. Time mode of growth hormone (GH) entry into the bloodstream and steady-state plasma GH concentrations, rather than sex, estradiol or menstrual cycle stage, primarily determine the GH elimination rate in healthy young men and women. J. Clin. Endocrinol. Metab. 84 (1999) 2862-2869
4. van den Berg G., Veldhuis J.D., Frolich M., and Roelfsema F. An amplitude-specific divergence in the pulsatile mode of growth hormone (GH) secretion underlies the gender difference in mean GH concentrations in men and premenopausal women. J. Clin. Endocrinol. Metab. 81 (1996) 2460-2467
5. Janssen Y.J., Frolich M., and Roelfsema F. The absorption profile and availability of a physiological subcutaneously administered dose of recombinant human growth hormone (GH) in adults with GH deficiency. Br. J. Clin. Pharmacol. 47 (1999) 273-278
6. Sesmilo G., Miller K.K., Hayden D., and Klibanski A. Inflammatory cardiovascular risk markers in women with hypopituitarism. J. Clin. Endocrinol. Metab. 86 (2001) 5774-5781
7. Burman P., Broman J.E., Hetta J., Wiklund I., Erfurth E.M., Hagg E., and Karlsson F.A. Quality of life in adults with growth hormone (GH) deficiency: response to treatment with recombinant human GH in a placebo controlled trial. J. Clin. Endocrinol. Metab. 80 (1995) 3585-3590
8. Swearingen B., Barker II F.G., Katznelson L., et al. Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J. Clin. Endocrinol. Metab. 83 (1998) 3419-3426
9. Biller B.M.K., Samuels M.H., Zagar A., et al. Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. J. Clin. Endocrinol. Metab. 87 (2002) 2067-2079
10. Drake W.M., Coyte D., Camacho-Hubner C., et al. Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults. J. Clin. Endocrinol. Metab. 83 (1998) 3913-3919
11. Cook D.M., Ludlam W.H., and Cook M.B. Route of estrogen administration helps to determine growth hormone (GH) replacement dose in GH-deficient adults. J. Clin. Endocrinol. Metab. 84 (1999) 3956-3960